PTPN2 and neoplasm: Protein loss was found to be related to worse survival in patients with tumours with NHG 2, with a similar trend for NHG 1, whilst PTPN2 copy loss was associated with worse survival in patients with tumours with NHG 1, neither was associated with DRFS at a high grade (Fig. 3a–f).